Belo Horizonte, MINAS%20GERAIS1 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Belo Horizonte, MINAS%20GERAIS

Find 1 actively recruiting myalgic encephalomyelitis clinical trials in Belo Horizonte, MINAS%20GERAIS. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
225
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Belo Horizonte

About Myalgic Encephalomyelitis Clinical Trials in Belo Horizonte

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 1 myalgic encephalomyelitis clinical trials recruiting participants in Belo Horizonte, MINAS%20GERAIS. These studies are seeking a combined 225 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Belo Horizonte — FAQ

Are there myalgic encephalomyelitis clinical trials in Belo Horizonte?

Yes, there are 1 myalgic encephalomyelitis clinical trials currently recruiting in Belo Horizonte, MINAS%20GERAIS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Belo Horizonte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Belo Horizonte research site will contact you about next steps.

Are clinical trials in Belo Horizonte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Belo Horizonte studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 1 active trials in Belo Horizonte are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov